SCHEMBL19754267

SCHEMBL19754267

CCN(c1ccccc1)c1nc(Cl)nc(Nc2cccc3cc(S(=O)(=O)O)c(/N=N/c4ccccc4S(=O)(=O)O)c(O)c23)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FUT8 Q9BYC5 1/20 0.58
▸ CYP1A2 P05177 4/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ DNASE1L3 Q13609 1/20 0.39
▸ NR4A1 P22736 1/20 0.36
▸ ENPP2 Q13822 3/20 0.35
▸ TTR P02766 1/20 0.35
▸ FABP4 P15090 1/20 0.35
▸ CCNA2 P20248 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ MAPK14 Q16539 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ PRMT1 Q99873 2/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ THRB P10828 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ CARM1 Q86X55 1/20 0.33
▸ HPGDS O60760 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8628450 0.91 FUT8 (0.71) FUT8CYP1A2MAPK1CYP2C9DNASE1L3
SCHEMBL8628445 0.91 FUT8 (0.71) FUT8CYP1A2MAPK1CYP2C9DNASE1L3
SCHEMBL19754266 0.90 FUT8 (0.60) FUT8CYP1A2MAPK1CYP2C9DNASE1L3
SCHEMBL19754269 0.90 FUT8 (0.47) FUT8CYP1A2MAPK1CYP2C9DNASE1L3
SCHEMBL14408152 0.87 FUT8 (0.56) FUT8CYP1A2MAPK1CYP2C9DNASE1L3
SCHEMBL12173260 0.85 FUT8 (0.58) FUT8CYP1A2MAPK1CYP2C9DNASE1L3
SCHEMBL12589954 0.85 FUT8 (0.58) FUT8CYP1A2MAPK1CYP2C9DNASE1L3
SCHEMBL18218141 0.83 FUT8 (0.68) FUT8CYP1A2MAPK1CYP2C9DNASE1L3
SCHEMBL12172963 0.83 FUT8 (0.58) FUT8CYP1A2MAPK1CYP2C9DNASE1L3
SCHEMBL14022709 0.83 FUT8 (0.58) FUT8CYP1A2MAPK1CYP2C9DNASE1L3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170369721-A1 INK COMPOSITION, INK SET, AND RECORDING METHOD SEIKO EPSON CORPORATION (JP) 2017-12-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369721-A1 INK COMPOSITION, INK SET, AND RECORDING METHOD IK, SETDB1, SET FUT8 2224/4885CYP1A2 269/4885MAPK1 1345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback